The secretariat to the committee is provided by the Immunisation section of the Department of Health. The Agenda is agreed between the Chairman and the secretariat and includes issues raised by members, through letters to the committee and by the Ministers of Health. Until recently the advice that the committee OSI-906 mouse provided to Ministers was just that advice. However, relevant provisions of the NHS Constitution
were enacted via Regulations which came into force on 1st April 2009. The Regulations specify that the public in England have the right to receive vaccinations as specified in any “Recommendation” of the committee that relates to a new national vaccination programme or to changes to an existing national
vaccination programme. The Recommendation must be on a question specifically referred by the Secretary of State, be based on an assessment which demonstrates cost-effectiveness and not relate to travel or occupational health. All other decisions of the JCVI are merely advisory. The JCVI adopted new terms of reference at their meeting on 17th June 2009. They are (in part): “To advise the Secretary of State for Health and Welsh SB203580 concentration Ministers on matters relating to communicable diseases, preventable and potentially preventable through vaccination and immunisation”. The JCVI’s statutory functions do not relate to Rolziracetam Scotland or Northern Ireland although their Ministers may choose to accept
its advice. The role of the committee in ultimate decision making is discussed further below. There is a JCVI code of practice for members which is published on the committee website (http://www.dh.gov.uk/ab/JCVI/index.htm), however a revised Code of Practice and JCVI Protocol are in development. At each meeting all members must declare any potential conflicts of interest and a register of such interests is maintained and published on the website. These potential conflicts are classified as personal or non-personal. Personal conflicts arise where the individual has themselves received money for consultancies with industry, fee paid work where industry pays the member in cash or kind or where the members holds shares in a company (actual sums of money are not given in the declaration). Industry here refers to companies, partnerships of individuals who are involved with the manufacture, promotion or supply of vaccines, trade associations representing such companies or similar bodies engaged in research and development or marketing of products under consideration by the committee. Non-personal conflicts are those where payment benefits a department for which a member is responsible but is not received by the member personally. The usual examples are industry funded grants and fellowships, payments of salaries for staff or sponsorship of research by industry.